Laszlo Muszbek
Overview
Explore the profile of Laszlo Muszbek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1084
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Somodi L, Horvath E, Bardos H, Barath B, Petho D, Katona E, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902231
Macrophages express the A subunit of coagulation factor XIII (FXIII-A), a transglutaminase which cross-links proteins through Nε-(γ-L-glutamyl)-L-lysyl iso-peptide bonds. Macrophages are major cellular constituents of the atherosclerotic plaque; they may...
2.
Bogati R, Katona E, Shemirani A, Balogh E, Bardos H, Jeney V, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628664
Plasma factor XIII (pFXIII) is a heterotetramer of FXIII-A and FXIII-B subunits. The cellular form (cFXIII), a dimer of FXIII-A, is present in a number of cell types. Activated FXIII...
3.
Somodi L, Debreceni I, Kis G, Cozzolino M, Kappelmayer J, Antal M, et al.
J Thromb Haemost
. 2022 Feb;
20(5):1223-1235.
PMID: 35146910
Background: Platelets contain a high amount of potentially active A subunit dimer of coagulation factor XIII (cellular FXIII; cFXIII). It is of cytoplasmic localization, not secreted, but becomes translocated to...
4.
Raut S, Katona E, Riches-Duit A, Coxon C, Muszbek L, Schroeder V, et al.
J Thromb Haemost
. 2021 Nov;
20(2):525-531.
PMID: 34784091
Background: Factor XIII (FXIII)-B subunit measurements are required for the diagnosis and characterization of the type of FXIII deficiency. Furthermore, therapy for FXIII-A deficiency with recombinant FXIII (rFXIII-A) relies on...
5.
Plamenova I, Zolkova J, Sokol J, Kolkova Z, Bereczky Z, Katona E, et al.
Semin Thromb Hemost
. 2021 Jun;
47(7):885-889.
PMID: 34111896
No abstract available.
6.
Barath B, Bogati R, Miklos T, Kallai J, Mezei Z, Bereczky Z, et al.
Thromb Res
. 2021 May;
203:110-116.
PMID: 33992873
Introduction: Alpha2-plasmin inhibitor (α2-PI) has a heterogeneous composition in the plasma. Both N- and C-terminal cleavages occur that modify the function of the molecule. C-terminal cleavage converts the plasminogen-binding form...
7.
Penzes K, Hurjak B, Katona E, Becs G, Balla J, Muszbek L
Int J Mol Sci
. 2020 Nov;
21(22).
PMID: 33182600
Hemostasis disorder in patients with end-stage renal disease (ESRD) is frequently associated with bleeding diathesis but it may also manifest in thrombotic complications. Analysis of individual coagulation and fibrinolytic factors...
8.
Bovet J, Hurjak B, De Maistre E, Katona E, Penzes K, Muszbek L
J Thromb Haemost
. 2020 Apr;
18(6):1330-1334.
PMID: 32311817
Hemorrhagic diathesis due to anti-factor XIII (FXIII) autoantibody is a rare but severe disorder. Challenges of the diagnosis and treatment is demonstrated by the case of a 67-year-old female without...
9.
Hurjak B, Kovacs Z, Donczo B, Katona E, Haramura G, Erdelyi F, et al.
J Thromb Haemost
. 2020 Mar;
18(6):1302-1309.
PMID: 32168410
Background: The protective/inhibitory B subunits of coagulation factor XIII (FXIII-B) is a ~80 kDa glycoprotein containing two N-glycosylation sites. Neither the structure nor the functional role of the glycans on...
10.
Kattula S, Bagoly Z, Toth N, Muszbek L, Wolberg A
J Thromb Haemost
. 2020 Jan;
18(4):885-894.
PMID: 31989767
Background: Factor XIII (FXIII) promotes fibrin crosslinking and red blood cell (RBC) retention in clots. The FXIII-A polymorphism, Val34Leu, is associated with protection against venous thrombosis. This effect is hypothesized...